Allogene Therapeutics Statistics
NASDAQ: ALLOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.6277-0.0392 (-5.88%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Allogene Therapeutics by the numbers
Allogene Therapeutics has a market capitalization of $217.5 million based on 346.47M shares outstanding. With trailing EPS of $-0.61, Allogene Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 51.8% below its 50-day average and 67.4% below its 200-day average.
Average daily trading volume is 7.69M shares, or about $4.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALLO valuation vs. peer median
| Metric | ALLO | Peer median | Difference |
|---|---|---|---|
| Market cap | $217.48M | $220.07M | -1% |
| Avg. volume | 7.69M | 1.27M | +504% |
Peer median across 8 companies: IPSC, SCTX, CABA, LCTX, AUTL, PLX, LXEO, ARTV.
Valuation
- Market cap
- $217.48M
- EPS (TTM)
- $-0.61
- Shares outstanding
- 346.47M
Price and trading
- Previous close
- 0.6669
- Open
- 0.642
- Day range
- 0.6192 – 0.67
- 52-week range
- 0.6192 – 4.46
- 52-week change
- -48.97%
- Beta
- —
- Volume
- 7.57M
- Average volume
- 7.69M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 217.48M
- Forward Pe
- -1.06
- Eps
- -0.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.46
- Week52 Low
- 0.62
- Avg Volume
- 7.69M
- Shares Outstanding
- 346.47M
- Ma50
- 1.30
- Ma200
- 1.92
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -85.93%
- Pct From52w Low
- 1.37%